Extracts of Phellinus gilvus and Phellinus baumii inhibit pulmonary inflammation induced by lipopolysaccharide in rats

Biotechnology Letters

Volumn 26, Issue 1, 2004, Pages 31-33

  Jang, Beom Su ^a   Kim, Jong Chun ^b   Bae, Jae Sung ^c   Rhee, Man Hee ^c   Jang, Kwang Ho ^c   Song, Jae Chan ^c   Kwon, Oh Deog ^c   Park, Seung Chun ^c  

^a Chungnam National University   (South Korea)

^b Chonnam National University   (South Korea)

^c Kyungpook National University   (South Korea)

Author keywords

Inflammation; Neutrophilia; Phellinus baumii; Phellinus gilvus; Rats

Indexed keywords

CELL EXTRACT; INTERLEUKIN 1; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BASIDIOMYCETES; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOLOGY; DRUG EFFECT; LEUKOCYTE COUNT; LUNG LAVAGE; MALE; METABOLISM; NEUTROPHIL; ORIENTAL MEDICINE; PATHOLOGY; PNEUMONIA; RAT; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANIMALS; BASIDIOMYCOTA; BRONCHOALVEOLAR LAVAGE FLUID; CELL EXTRACTS; INTERLEUKIN-1; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MEDICINE, ORIENTAL TRADITIONAL; NEUTROPHILS; PNEUMONIA; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; BASIDIOMYCOTA; FUSCOPORIA GILVA; INONOTUS BAUMII; PHELLINUS;

EID: 0842288724     PISSN: 01415492     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BILE.0000009456.63616.32     Document Type: Article

References (8)

1. Ajith TA, Janardhanan KK (2002) Antioxidant and antihepatotoxic activities of Phellinus rimosus (Berk) Pilat. J. Ethnopharmacol. 81: 387-391.
2. Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH, Kim HM (1999) The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis. Immunopharmacology 41: 157-164.
3. Kim HM, Han SB, Oh GT, Kim YH, Hong DH, Hong ND, Yoo ID (1996) Stimulation of humoral and cell mediated immunity by polysaccharide from mushroom Phellinus linteus. Int. J. Immunopharmacol. 18: 295-303.
4. Makristathis A, Stauffer F, Feistauer SM, Georgopoulos A (1993) Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia. Infect. Immun. 61: 1996-2002.
5. Sears MR (1997) Descriptive epidemiology of asthma. Lancet 350 (Suppl 2): SII1-SII4.
6. Spond J, Chapman R, Fine J, Jones H, Kreutner W, Kung TT, Minnicozzi M (2001) Comparison of PDE 4 inhibitors, rolipram and SB 207499 (ariflo), in a rat model of pulmonary neutrophilia. Pulm. Pharmacol. Ther. 14: 157-64.
7. Spond J, Case N, Chapman RW, Crawley Y, Egan RW, Fine J, Hey JA, Kreutner W, Kung T, Wang P, Minnicozzi M (2003) Inhibition of experimental acute pulmonary inflammation by pirfenidone. Pulm. Pharmacol. Ther. 16: 207-214.
8. Warren JS, Barton PA, Mandel DM, Matrosic K (1990) Intrapulmonary tumor necrosis factor triggers local platelet-activating factor production in rat immune complex alveolitis. Lab. Invest. 63: 746-754.